www.fdanews.com/articles/69922-cyclacel-and-altana-pharma-announce-collaboration
Cyclacel and ALTANA Pharma Announce Collaboration
March 16, 2005
Cyclacel Group, the cell cycle-based biopharmaceutical company, announced execution of a research collaboration agreement with ALTANA Pharma AG, the pharmaceutical division of ALTANA AG, in which Cyclacel will use its expertise in mitosis or cell division to identify the molecular targets of specific ALTANA Pharma experimental drugs. Under the terms of the agreement ALTANA Pharma will supply Cyclacel with selected experimental molecules shown to interfere with mitosis.